Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine whether 2 weeks of treatment with AZD1446 compared to placebo improves ADHD symptoms and is well tolerated.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01012375
Study type Interventional
Source AstraZeneca
Contact
Status Completed
Phase Phase 2
Start date November 2009
Completion date August 2010

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03494478 - Emotional Dysregulation in Adult ADHD. N/A
Completed NCT01939353 - Study of Flexible Doses of the Triple Reuptake Inhibitor EB-1020 Sustained Release (SR) in the Treatment of Adult Males With Attention-Deficit Hyperactivity Disorder Phase 2
Active, not recruiting NCT03437993 - Recollect the Game: A Novel Treatment for Executive Functioning Deficits in Adults With ADHD N/A
Active, not recruiting NCT06040996 - Evaluation of Improving Parenting Skills Adult ADHD (IPSA): A New Parent Training Program for Parents With ADHD N/A
Recruiting NCT05832489 - EEG-MRI Imaging of Methylphenidate Effects in Adult ADHD and Attentional Symptoms in Mood Disorders Phase 3
Completed NCT00318981 - Efficacy of Concerta in Treating ADHD in Mothers of Children With ADHD Phase 4